Pd 1
Overview
Product sourcing insights & recommendations
The PD-1 and PD-L1 inhibitors market is undergoing a major clinical and commercial transformation as it enters 2026. While the market continues to grow at a double-digit CAGR of ~13.5%, the landscape is shifting from breakthrough discovery toward clinical maturity, driven by subcutaneous administration, patent cliffs, and the imminent arrival of biosimilars.
Key Findings:
* Market Size & Leadership: The global market is valued at $62.1B–$74.2B in 2026, with Merck’s Keytruda holding a dominant 49% share followed by BMS’s Opdivo at 26%.
* Major Emerging Trends:
* Subcutaneous (SC) Shift: Manufacturers are transitioning from IV infusions to SC injections (e.g., SC Keytruda/Opdivo) to combat patent cliffs and enhance patient convenience.
* Biosimilar Disruption: The entry of biosimilars (like Amgen’s ABP-243) is expected to rapidly capture up to 50% of the market post-patent expiry.
* Commercial Sourcing: Research-grade PD-1 ELISA kits and monoclonal antibodies are widely available, with kits typically priced between $160 and $420 per box.
The detailed report below provides a comprehensive breakdown of market shares, regional growth in Asia-Pacific, and Google Trends analysis for 2026.
Here is the PD-1 market and trend analysis. You can explore further with:
Pd 1 Elisa Kit
Products · 2 lists
Human Programmed Cell Death Protein 1 (PD-1)ELISA Kit
Hangzhou Shenglong Import And Export Trade Co., Ltd.🇨🇳CN5 yrs
Human programmed death-1(PD-1) ELISA Kit
Hubei Province Youqian Biotechnology Co., Ltd.🇨🇳CN1 yr
PD1(Protectin D1) ELISA Kit ELK0497 | Competitive Inhibition
Elk (wuhan) Biotechnology Co., Ltd.🇨🇳CN3 yrs
Human PD-L1(Programmed Cell Death Protein 1 Ligand 1) ELISA Kit
Wuhan Elabscience Biotechnology Co., Ltd.🇨🇳CN2 yrs
Human Procollagen 1 N-terminal Peptide,P1NP ELISA Research Kit
Forevertech Biotechnologies Co.,ltd.🇨🇳CN1 yr
Deoxynivalenol (DON) ELISA Kit Veterinary Instrument for Detecting Feed Grain Corn 96T/Box
Nanjing Pars Biochem Co., Ltd.🇨🇳CN4 yrs
Mouse PDGF-BB ELISA Kit-Sandwich ELISA for Serum/Plasma 0.156-10ng/ml Sensitivity
Wuhan Fine Biotech Co., Ltd.🇨🇳CN3 yrs
BPE039 Human Basigin, BSG Primacu ELISA Kit
Jiaxing Korain Biotech Co., Ltd.🇨🇳CN3 yrs
Laboratory Reagents PCS (Pentachlorophenol Sodium) ELISA Kit
Beijing Wdwk Biotechnology Co., Ltd.🇨🇳CN7 yrs
Elisa Kits Tests Strips T3 T4 TSH HBA1C Open System Can Work with All Elisa Machines DiaSino Control Set
Shenzhen Lethealth Technology Co., Ltd.🇨🇳CN6 yrs
Human Rac1 ELISA Kit 96 Well Research Grade
Wuhan Koolbio Technology Co. Ltd🇨🇳CN2 yrs
Pseudorabies Virus (PRV) gE Antibody ELISA Kit for Swine - DIVA-Compatible & High Specificity
Neacov Biological Technology Co., Ltd.🇨🇳CN2 yrs
Green Spring LSY-30027 Pullorum Disease (PD) and Fowl Typhoid (FT) Antibody ELISA Test Kit for Serum
Shenzhen Lvshiyuan Biotechnology Co., Ltd.🇨🇳CN16 yrsDeep Dive · Full Report
Full Market Report
1 document · Live-fetched from source
Related Searches
Explore more sourcing topics & related categories
Sources & References
21 sources cited · Verified industry data & reports
PD-1 & PD-L1 Inhibitors Market Growth Report 2031
Mordor Intelligence
The PD-1 And PD-L1 Inhibitors Market worth USD 74.16 billion in 2026 is growing at a CAGR of 13.88% to reach USD 142.04 billion by 2031.
Global PD-1/PD-L1 Inhibitors Market $151.1 Billion by 2034
ihealthcareanalyst.com
The global market for PD-1/PD-L1 inhibitors predicted to reach $151.1 billion by 2034, expanding at a double-digit CAGR of 11.9% growth trends ...
PD-1 and PD-L1 Inhibitor Pipeline, Therapies, Companies, ...
DelveInsight
DelveInsight's “PD-1 and PD-L1 Inhibitors Competitive Landscape, 2026” report provides comprehensive insights about 180+ companies and 200+ drugs in the PD-1
Explore the Global PD-1/PDL-1 Inhibitor Market
Future Market Insights
The PD-1/PDL-1 Inhibitor Market worth USD 67996.6 million in 2026 is growing at a CAGR of 13.1% to reach USD 232839.8 million by 2036.
PD-1 and PD-L1 Inhibitors market
The PD-1 and PD-L1 Inhibitors Market is experiencing substantial growth, driven by rising cancer prevalence and advancements in immunotherapy.
PD-1 and PD-L1 Inhibitor Market Size & YoY Growth Rate, ...
Coherent Market Insights
PD-1 Inhibitors is anticipated to hold 63.3% of the market share in 2026 due to their versatility in treating various cancer types.